Bicara Therapeutics (BCAX) News
NASDAQ: BCAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.50+0.24 (+1.39%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BCAX news summary
We found 1 recent headline mentioning Bicara Therapeutics (BCAX): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, BCAX is up 1.39% at $17.50. The most recent story, "Pliant Therapeutics Names David Raben As CMO To Lead PLN-101095 Development", was published by Nasdaq on Oct 1, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology